drugset / Trial / NCT00465699

Evaluation of Topical B12 for the Treatment of Childhood Atopic Dermatitis

NCT00465699

RandomizedSingle-groupDouble-blindTreatment

Summary

This study is being done to see in B12 applied to the skin will improve the symptoms of eczema in children compared to a placebo creme

Timeline

Start
2007-04
Primary completion
Completion
2007-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Vitamin B12 Other / unclassified 0.07 % Topical

Indications